What Is the First-Line Treatment for Transverse Myelitis?

Transverse myelitis is an acute inflammatory condition of the spinal cord that can cause rapid neurological deterioration. Early intervention is central to limiting injury and supporting recovery of function.

First-Line Approach

Initial management typically involves high-dose intravenous corticosteroid therapy, aimed at hastening recovery and reducing active inflammation. The complete regimen — including agent selection, dosing schedule, and duration — is detailed in the structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1212/WNL.0b013e31823dc535
Despite the absence of evidence, administration of high-dose IV methylprednisolone (1 g daily for 3 to 7 days) is typically the first treatment offered to hasten recovery, reduce disease activity, and restore neurologic function.

View source ↗